2023 Annual Gala Journal

WELCOME TO THE LYMPHOMA RESEARCH FOUNDATION’S

Annual Gala Ziegfeld Ballroom

SEPTEMBER 28, 2023

Dear Friends,

It is with distinct pleasure that we welcome you to the Lymphoma Research Foundation’s (LRF) 2023 Annual Gala. Tonight is a special celebration, as we gather to celebrate our most deserving honorees and recognize their work to support the Foundation and the greater lymphoma community.

This evening we are delighted to recognize two innovators in lymphoma research and dedicated patient advocates. LRF will present Kara M. Kelly, MD with our Distinguished Leadership Award in recognition of her work as a trailblazing lymphoma researcher, dedicated pediatric oncologist, and global expert in the field of adolescent and young adult (AYA) blood cancers. Dr. Kelly is also a member of LRF’s prestigious Scientific Advisory Board and Co-Chair of the Foundation’s international AYA Lymphomas Consortium. Genmab will be presented with the LRF Corporate Leadership Award for the company’s pioneering work in antibody therapeutics for the treatment of cancer and supporting the Foundation’s research initiatives and educational programs for people with lymphoma/CLL and their care partners.

This year, we gather to share the many stories of hope made possible by the Lymphoma Research Foundation. Your support to the Annual Gala allows LRF to make greater investments in scientific breakthroughs and improved patient care. The legacy and lasting impact of this evening’s event will touch patients, caregivers, physicians, and the entire cancer community in ways beyond measure. It is with deep gratitude that we thank you for the hope you make possible for those with lymphoma.

With gratitude,

Steven Eichberg Chair, Board of Directors, Lymphoma Research Foundation

Meghan Gutierrez Chief Executive Officer, Lymphoma Research Foundation

VIDEO

WELCOME

Steven Eichberg

Chair, LRF Board of Directors

Meghan Gutierrez

Chief Executive Officer, LRF

CORPORATE LEADERSHIP AWARD

Genmab

Corporate Leadership Award Recipient

Presented by Meghan Gutierrez

Chief Executive Officer, LRF

LIVE AUCTION

Harry Santa-Ollala Auctioneer

AGENDA

DINNER

DISTINGUISHED LEADERSHIP AWARD

Kara M. Kelly, MD

Distinguished Leadership Award Recipient

Co-Presented by Michael A. Weiner, MD & Avery Hoffman

Chair, LRF Annual Gala & Grateful Patient

RAISE IT FOR LYMPHOMA RESEARCH FOUNDATION

Harry Santa-Ollala Auctioneer

CLOSING

DESSERT & REFRESHMENTS

EMERGING PHILANTHROPISTS AFTER PARTY

THANK YOU TO OUR SPONSORS*

PRESENTING

Genmab CHAMPION

Pharmacyclics LLC, an AbbVie Company and Jansen Biotech, administered by

Janssen Scientific Affairs

LEADER

The Hoffman Family

Kite, A Gilead Company

Lilly Oncology

Leigh & Cory Olson

Regeneron

Seagen

Susan & Jeffrey Sussman

The Werner Family

ADVOCATE

BeiGene

The Prince Family Foundation

ONLINE AUCTION

Harriet & Scott Greenberg

BENEFACTOR

AbbVie

Bristol Myers Squibb

Gladys Cook

Gail & Larry Dobosh

Barbara & Jerry Freundlich

Lynn & Mike Froy

John R. Oishei Children’s Hospital

Barrie & Glen Kassan

The Kelly Family

Merck

John A. Nelson

Donna, Don and Ben Riley

Roswell Park Comprehensive Cancer Center

PATRON

Lana & Michael Beaury

The Cohen Family

Jean & Steven Eichberg

Lori & Gary Gertzog

The Billi Marcus Foundation, Inc.

Stephanie & Steven Rosen

Rutgers Cancer Institute of New Jersey and RWJBarnabas Health

TRIBUTE

Linda & Denis Cronin

Doyen Consulting Group, LLC

Arlene Fischer

Nora & Mel Masuda

Morphosys

The Morris Family

Theodore Wojtech & Clair Lonegan

*as of September 26, 2023

DISTINGUISHED LEADERSHIP AWARD RECIPIENT

KARA M. KELLY, MD

Dr. Kelly is the Waldemar J. Kaminski Endowed Chair of Pediatrics at Roswell Park Comprehensive Center as well as Chief and Professor of Pediatric Hematology/Oncology at the University at Buffalo’s Jacobs School of Medicine and Biomedical Sciences. She also directs the Roswell Park Oishei Children’s Cancer and Blood Disorders Program, a collaboration integrating inpatient and outpatient services for children and adolescents with cancer or blood disorders.

Specializing in care for children with hematological malignancies over a three-decade career at National Cancer Institute-designated comprehensive cancer centers, Dr. Kelly has designed and led numerous nationwide research studies that resulted in practice-changing insights and new, higher standards of care for children and young adults with high-risk Hodgkin lymphoma. She holds an MD from the University at Buffalo’s Jacobs School,

and completed both residency and fellowship in pediatric hematology/oncology at the Children’s Hospital of Philadelphia.

Dr. Kelly is a clinical researcher who is dedicated to bringing accomplished experts together to advance outcomes and quality of life for adolescents and young adult patients with Hodgkin lymphoma through clinical trials of novel targeted or immunotherapeutic approaches. She joined the Lymphoma Research Foundation as a Scientific Advisory Board member in 2015 and has served as founding Co-Chair of LRF’s Adolescent and Young Adult Consortium since 2021. She contributes to the development of treatment standards as Chair of the National Comprehensive Cancer Network (NCCN) Pediatric Hodgkin Lymphoma Guidelines Panel, and is a past Chair (2011-2022) of the National Cancer Institute-supported Children’s Oncology Group’s Hodgkin Lymphoma Committee.

CORPORATE LEADERSHIP AWARD RECIPIENT

Genmab is an international biotechnology company with a core purpose guiding its unstoppable team to strive towards improving the lives of patients through innovative and differentiated antibody therapeutics. For more than 20 years, its passionate, innovative and collaborative team has invented next-generation antibody technology platforms and leveraged translational research and data sciences, which has resulted in a proprietary pipeline including bispecific T-cell engagers, next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates.

To help develop and deliver novel antibody therapies to

patients, Genmab has formed 20+ strategic partnerships with biotechnology and pharmaceutical companies. By 2030, Genmab’s vision is to transform the lives of people with cancer and other serious diseases with Knock-Your-Socks-Off (KYSO) antibody medicines.

Established in 1999, Genmab is headquartered in Copenhagen, Denmark with locations in Utrecht, the Netherlands, Princeton, New Jersey, U.S. and Tokyo, Japan.

For more information, please visit Genmab.com and follow us on Twitter.com/Genmab

AUCTIONEER

HARRY SANTA-OLALLA

Born and raised in the UK, Harry began his fundraising career in London. He worked closely with many of the UK’s largest not for profits on many of their most high-profile campaigns. Identifying New York as the fundraising capital of the world, he ‘hopped the pond’ and burst onto the NYC gala scene in 2012 and has not looked back since.

Harry now supports many of the biggest not for profits stateside, both as a pre-campaign consultant, and on stage during the events

themselves as the auctioneer. He has a methodical approach to fundraising; utilizing data from previous years, as well as analysis of event formats and guest demographic to help clients set and challenge their audience to achieve ambitious fundraising goals.

Harry prides himself on maximizing audience participation in the auction or pledge drive call to action. He has a unique ability to tastefully draw something out of everyone, uniting rooms to a common fundraising goal, coupled with integrity and a sharp wit!

THANK YOU TO OUR BENEFIT COMMITTEE

Jeff Block

Gladys Cook

Gail & Larry Dobosh

Jean & Steven Eichberg

Arlene Fischer

Barbara & Jerry Freundlich

Lynn & Michael Froy

Harriet & Scott Greenberg

Mary Jo & Thomas Habermann, MD

Barrie & Glen Kassan

Ann S. LaCasce, MD, MMSc

Leah & John P. Leonard, MD

Kimberly Metcalf

John A. Nelson

Leigh & Cory Olson

Debbie & Steve Prince

Stephanie & Steven Rosen

Sonali M. Smith, MD, FASCO

Susan & Jeffrey Sussman

Laura & Michael Werner

Robert Werner

THANK YOU TO OUR

AUCTION COMMITTEE

Harriet Greenberg

Leigh Olson

Donna Reinbolt

EMERGING PHILANTHROPISTS COMMITTEE

Sarah E. Berlinger

Céline Bossart

Avery Hoffman

Katie McClenahan

Erin Mulvey, MD

Paula Ngon

Alexandra Rose

Isabel Sessions

Sanket Shah, PhD

Margot Werner

STEVEN EICHBERG Chair

Plymouth, MA

JEFF BLOCK

Vice Chair and Treasurer

San Francisco, CA

KIM METCALF

Vice Chair

Landenberg, PA

LEIGH OLSON Secretary

Miami Beach, FL

MICHAEL FROY

Chicago, IL

HARRIET GREENBERG

New York, NY

BOARD OF DIRECTORS

ANN S. LACASCE, MD, MMSC

Chair, Scientific Advisory Board

Boston, MA

JOHN LEONARD, MD

Past Chair, Scientific Advisory Board

New York, NY

BOB MCAULEY

Charlottesville, VA

JOHN A. NELSON

Westport, CT

SCOTT PANSKY

Tarzana, CA

JOEL POLLICK

Brooklyn, NY

KEVIN SHEA

Naples, FL

RAMESH SUBRAHMANIAN Singapore

MICHAEL WERNER Past Chair

Chicago, IL MEMBERS EMERITUS

MORTON COLEMAN, MD

New York, NY

BARBARA FREUNDLICH Founder

New York, NY

JERRY FREUNDLICH IN MEMORIUM

Founder and Past Chair

New York, NY

TOM GOLDSTONE

New York, NY

STEVEN J. PRINCE

Past Chair

Purchase, NY

DONNA REINBOLT

Houston, TX

ROBERT WERNER

Aventura, FL

SCIENTIFIC ADVISORY BOARD

The Lymphoma Research Foundation’s volunteer Scientific Advisory Board, comprised of 45 world-renowned lymphoma experts, guides the Foundation’s research activities, seeking out the most innovative and promising lymphoma research projects for support.

ANN S. LACASCE, MD, MMSC

Chair

Harvard Medical School

Dana-Farber Cancer Institute

ANDREW M. EVENS, DO, MSc, FACP

Chair-Elect

Rutgers Cancer Institute of New Jersey

RANJANA ADVANI, MD

Stanford University School of Medicine

ASH A. ALIZADEH, MD, PhD

Stanford University School of Medicine

STEPHEN ANSELL, MD, PhD

Mayo Clinic, Rochester

KRISTIE A. BLUM, MD

Winship Cancer Institute of Emory University

JENNIFER BROWN, MD

Dana-Farber Cancer Institute

JAMES CERHAN, MD, PhD Mayo Clinic, Rochester

ETHEL CESARMAN, MD, PhD

NewYork-Presbyterian Hospital

Weill Cornell Medicine

BRUCE D. CHESON, MD, FACP, FAAAS, FASCO

Past Chair, 2010-2012

The Center for Cancer and Blood Disorders

SANDEEP DAVE, MD, MS

Duke University

KIERON M. DUNLEAVY, MD

Lombardi Cancer Center of Georgetown University

KOJO S.J. ELENITOBA-JOHNSON, MD

Memorial Sloan Kettering Cancer Center

CHRISTOPHER R. FLOWERS, MD, MS

The University of Texas

MD Anderson Cancer Center

JONATHAN W. FRIEDBERG, MD, MMSc

University of Rochester

James P. Wilmot Cancer Institute

SCIENTIFIC ADVISORY BOARD CONT.

LEO I. GORDON, MD, FACP

Past Chair, 2015-2017

Robert H. Lurie Comprehensive Cancer Center of Northwestern University

MICHAEL GREEN, PhD MD

The University of Texas MD Anderson Cancer Center

THOMAS M. HABERMANN, MD

Past Chair, 2017-2019

Mayo Clinic, Rochester

STEVEN M. HORWITZ, MD

Memorial Sloan Kettering Cancer Center

ERIC D. HSI, MD

Wake Forest

BRAD S. KAHL, MD

Washington University School of Medicine

KARA KELLY, MD

Roswell Park Comprehensive Cancer Center

University at Buffalo Jacobs School of Medicine

JOHN P. LEONARD, MD

Past Chair, 2012-2015

NewYork-Presbyterian Hospital

Weill Cornell Medicine

IZIDORE S. LOSSOS, MD

University of Miami Health System

Sylvester Comprehensive Cancer Center

PETER MARTIN, MD

Weill Cornell Medicine

ARI MELNICK, MD

NewYork-Presbyterian Hospital

Weill Cornell Medicine

LINDSAY MORTON, PhD

National Cancer Institute

MARKUS MÜSCHEN, MD, PhD Yale School of Medicine

LORETTA NASTOUPIL, MD

The University of Texas

MD Anderson Cancer Center

TERESA PALOMERO, PHD

Institute for Cancer Genetics, Columbia University

LAURA PASQUALUCCI, MD

Institute for Cancer Genetics, Columbia University

BARBARA PRO, MD Columbia University

SCIENTIFIC ADVISORY BOARD CONT.

LISA RIMSZA, MD

Mayo Clinic, Arizona

LISA ROTH, MD

Weill Cornell Medicine

KERRY J. SAVAGE, MD

British Columbia Cancer

DAVID SCOTT, MBCHB, MD

BC Cancer, Vancouver

LAURIE SEHN, MD, MPH

BC Cancer, Vancouver

MARGARET SHIPP, MD

Harvard Medical School

Dana-Farber Cancer Institute

SONALI M. SMITH, MD

Immediate Past Chair, 2021-2023

The University of Chicago

EDUARDO M. SOTOMAYOR, MD

Tampa General Hospital

CHRISTIAN STEIDL, MD

BC Cancer, Vancouver

JOHN M. TIMMERMAN, MD

UCLA Jonsson Comprehensive Cancer Center

SVEN de VOS, MD, PhD

UCLA Jonsson Comprehensive Cancer Center

HANS-GUIDO WENDEL, MD

Memorial Sloan Kettering Cancer Center

ANDREW D. ZELENETZ, MD, PhD

Past Chair, 2019-2021

Memorial Sloan Kettering Cancer Center

SAB EMERITUS

MORTON COLEMAN, MD

New York-Presbyterian Hospital

Weill Cornell Medicine

BRIAN LINK, MD

University of Iowa

KANTI R. RAI, MD

Donald and Barbara Zucker School of Medicine at Hofstra/Northwell

MICHAEL E. WILLIAMS, MD, ScM

University of Virginia Cancer Center

Thank You To Our Sponsors

Rooted in science, inspired by patients

Genmab is honored and proud to support the Lymphoma Research Foundation’s important work for patients and their families.

Genmab congratulates

Kara M. Kelly, MD

for receiving this year’s Lymphoma Research Foundation’s Distinguished Leadership award for her life enhancing contributions to the lymphoma community

CONGRATULATIONS, AND WE ARE SO PROUD

all of the work that LRF and its community has been doing for the past 25 years.

Changing the way cancer is treated.

Kite’s singular focus is cell therapy to treat and potentially cure cancer.

Kite is a proud supporter of the Lymphoma Research Foundation’s work to eradicate lymphoma and serve those impacted by this blood cancer.

LEADER SPONSOR

IN HONOR AND MEMORY OF JERRY FREUNDLICH

We fondly remember his smile, sense of humor, love of music and golf, and of course, passion and leadership as a Founder of Cure for Lymphoma and Lymphoma Research Foundation. You will be missed, Jerry.

WITH

LOVE, LEIGH AND CORY OLSON

As a pioneer in antibody-drug conjugates (ADCs), Seagen has led the way in novel cancer therapeutics for 25 years. Now, as a global company with four approved therapies and a robust pipeline, we’re committed more than ever to improving lives for people with cancer around the world.

seagen.com

Seagen and the Seagen Logo are the registered trademarks of Seagen Inc. ©2023 Seagen Inc.

TONIGHT ESPECIALLY WE MOURN THE LOSS OF JERRY FREUNDLICH,

LRF’s founder and our dear friend.

Jerry was compassionate, generous, warm and persistent. His vision - and his partnership with Barbara - created a remarkable organization. We appreciate Barbara and Jerry, the LRF board and our physicians daily.

–

SUSAN AND JEFFREY SUSSMAN

THE WERNER FAMILY

mourns the loss of two incredible leaders, Errol Cook, Past-Chair of LRF’s Board of Directors and Jerry Freundlich, Co-Founder and Past-Chair of LRF’s Board of Directors. We are grateful for their relentless commitment which has advanced the work of the Lymphoma Research Foundation in countless ways. Their legacies will live on each day through the lives of the many survivors, volunteers, and staff who have been fortunate to be touched by their dedication to our mission.

– THE WERNER FAMILY

OUR THANKS TO

THE LRF STAFF,

THE SAB AND THE PHARMACEUTICAL INDUSTRY

for their efforts and successes in advancing lymphoma treatments and supporting the lymphoma community. We also want to recognize the massive contributions of two of our most stalwart supporters who passed away this year, Errol Cook and Jerry Freundlich.

– STEVE & DEBBIE PRINCE

CONGRATULATIONS TO KARA M. KELLY, MD AND GENMAB

on their much-deserved awards tonight, as well as Dr. JP Leonard and all the members of the SAB. We are honored to support the mission of the Lymphoma Research Foundation as they work to eradicate this blood cancer and support the entire lymphoma community.

– HARRIET & SCOTT GREENBERG

The toughest challenges. The most advanced science.

We fight the toughest health challenges with advanced science, putting our passion to work where the need is greatest. Our purpose as a global biopharmaceutical company is to make a remarkable impact on people’s lives.

abbvie.com

CONGRATULATIONS Kara Kelly, MD

for being honored with the Distinguished Leadership Award from the Lymphoma Research Foundation!

Directed by Dr. Kelly, the Roswell Park Oishei Children’s Cancer and Blood Disorders Program offers a comprehensive pediatric cancer program that is only 1 of 3 of its kind in the United States.

The program combines the best offerings of both healthcare institutions: advanced diagnostic testing, the newest clinical trials, bone marrow transplants, a highly-advanced pediatric intensive care unit and much more. Oishei Children’s Hospital is proud to partner in this exceptional program, ensuring that families in Buffalo and Western New York don’t need to leave the area to receive comprehensive, cutting-edge care.

Make an impact on cancer’s youngest patients today: FOROCH.org

“The expertise your child needs in cancer care is here, locally.”

IN LOVING MEMORY OF ERROL M. COOK,

a devoted husband, father, grandfather, the pillar of his family, and a leader in all of his life endeavors, twice chairman of LRF. You will always live in our hearts. – YOUR LOVING FAMILY

WE ARE PLEASED TO CELEBRATE THE MANY MEMBERS OF OUR LYMPHOMA COMMUNITY.

Congratulations to Dr. Kara Kelly for this well-deserved honor recognizing her innovative leadership. Congratulations to Genmab for the recognition of its work supporting lymphoma patients.

– GAIL & LARRY DOBOSH

WE

PROUDLY

SUPPORT THE LYMPHOMA RESEARCH FOUNDATION,

congratulate tonight’s honorees and thank them, the LRF staff, and the Scientific Advisory Board for making a difference in the lives of those touched by lymphoma.

– LYNN AND MIKE FROY

IN MEMORY OF JERRY FREUNDLICH.

A TIRELESS ADVOCATE FOR THOSE WITH LYMPHOMA.

Best wishes to our hero, Dr. Morton Coleman and the Lymphoma Research Foundation.

BARRIE & GLEN KASSAN, ALAYNA VINCENT, JORDAN, SAMUEL & MIKAH ZAYAS, ERICA, MICHAEL, DEXTER & HUDSON MOSCARELLO

KARA KELLY

- incredible physician, phenomenal mother, and amazing wife. We are so proud of you and your amazing accomplishments!

– YOUR LOVING FAMILY

Using the power of leading-edge science to save and improve lives around the world

For more than a century, we’ve been at the forefront of research, bringing forward medicines, vaccines and innovative health solutions for some of the world’s most challenging diseases.

At Merck, we rise to the challenge in pursuit of better health outcomes.

THE NELSON

IS PROUD TO SUPPORT THE EFFORTS OF THE LYMPHOMA RESEARCH FOUNDATION,

FAMILY

Congratulations to this evening’s honorees:

Kara M. Kelly, MD Genmab

– JOHN A. NELSON AND FAMILY

WARM CONGRATULATIONS TO DR. KARA M. KELLY

ON THIS WELL DESERVED RECOGNITION.

You have our everlasting gratitude for the outstanding care you provided to our family and to so many others.

– DONNA, DON AND BEN RILEY

RoswellPark.org

BENEFACTOR SPONSOR

Chair of the Roswell Park Oishei Children’s Cancer and Blood Disorders Program

Waldemar J. Kaminski Endowed Chair of Pediatrics

Roswell Park Comprehensive Cancer Center

Roswell Park Comprehensive Cancer Center is proud to celebrate Dr. Kara Kelly for her decades of dedication to children, young adults and families affected by cancer.

Your pioneering and collaborative work continues to lead to better treatments, quality of life and outcomes for lymphoma patients worldwide.

Kara M. Kelly, MD

IT IS WITH GREAT SADNESS THAT THE LYMPHOMA RESEARCH FOUNDATION (LRF) MOURNS THE PASSING OF ERROL M. COOK,

a two-time Chair of the LRF Board of Directors and Director Emeritus. Errol was devoted to his family and friends and was always a thoughtful, caring person who was willing to take time for anyone in need – especially those who received a lymphoma diagnosis. Errol is being remembered by his LRF family and patients and colleagues across the nation as a generous leader and a lymphoma survivor whose vision and compassion advanced the LRF mission for millions of patients and their families.

THE LYMPHOMA RESEARCH FOUNDATION MOURNS THE

LOSS

OF JERRY FREUNDLICH,

our Co-Founder and past Chair of the Foundation’s Board of Directors.

Jerry was an exceptional man of character, a respected advocate for the lymphoma community, a trusted friend in all things. Jerry’s passionate pursuit of a world free of lymphoma, sincerity, and kindness earned him the respect and admiration of all his colleagues. Jerry is being remembered by his LRF family as a lymphoma survivor whose generosity and vision have impacted the lives of millions of members of the lymphoma community.

IN MEMORIAM FOR LRF’S STALWARTS JERRY FREUNDLICH & ERROL COOK

DR.’S MORTON COLEMAN, MARK PASIMANTIER, JULIAN DECTER

IN HONOR OF GLADYS COOK

IN MEMORY OF ERROL COOK

– WITH LOVE, RELLYE & MARTIN CORWIN

THE LYMPHOMA RESEARCH FOUNDATION WOULD LIKE TO RECOGNIZE THE SUPPORTERS OF THE KANTI R. RAI SCHOLAR AWARD.

This award is supported by private philanthropy as well as Pharmacyclics, an AbbVie Company, AstraZeneca Pharmaceuticals, and Eli Lilly and Company.

The Kanti R. Rai Scholar Award was first created in 2022 and was established in recognition of Dr. Rai’s global leadership in the field of lymphoma/CLL research and his commitment to LRF’s mission.

IT IS WITH SADNESS THAT THE LRF STAFF MOURNS THE LOSS OF INCREDIBLE COLLEAGUE, MINDY CAMP FEDIDA.

We will always remember her for her kindness, dedication, and the enthusiastic spirit she brought to everything she did. Mindy was an exceptional person and will be deeply missed and remembered with fondness.

Thank You! to all those who continue to champion LRF each and every day:

Our Donors and our Partners from Pharma and Corporate,

Our Lymphoma Support Network Volunteers who guide our community every day,

Our entire LRF Staff who continue to do the hard work every day,

Our leadership…thank you Meghan Gutierrez for all that you do each and every day,

Our Board of Directors for providing support for our LRF staff and helping drive new initiatives to make us stronger,

Our Scientific Advisory Board for your passion to Find A Cure and your knowledge which you share throughout the year with patients, caregivers and families,

And our entire Lymphoma Community for sharing your Stories of Hope!

– STEVEN AND JEAN EICHBERG

IN HONOR OF DR. LEONARD AND HIS STAFF

Thank you for all you do for Lymphoma Research Foundation

– LORI AND GARY GERTZOG

WE

ARE PROUD TO SUPPORT THE EFFORTS OF THE

LYMPHOMA RESEARCH FOUNDATION

and offer our congratulations to tonight’s honorees.

– THE ROSEN FAMILY

TRIBUTE SPONSOR TRIBUTE SPONSOR

RHETT MORRIS Hodgkin Lymphoma Thriver

DON BOSCO PREP 2023 FOOTBALL O-LINE #64

Rhett Morris, continue to chase your dreams and make your mark on the football field. Off the field, always embody the true spirit of a leader and a team player. Your unwavering determination, positive attitude, and selflessness are qualities we all admire.

Congratulations, Rhett, on your truly remarkable achievements thus far, and here's to a future filled with countless victories, both on and off the field!

~ MOM & DAD

People living with cancer don �t just inspire us. They drive us.

At MorphoSys, we are motivated every day by our mission: More life for people with cancer. Learn more at MorphoSys.com.

IN PROUD SUPPORT OF LRF AND ITS MISSION.

Thank you to Meghan Gutierrez and her team who make an immense difference in the lives of lymphoma patients and their families every day. The knowledge and comfort you provide has made a difficult journey easier for so many.

– CORISSA DEROSE, DOYEN CONSULTING GROUP, LLC

IN MEMORY OF ROBERT FISCHER

CONGRATULATIONS TO DR. KARA KELLY

A Devoted Champion of LRF.

– FROM HIS LOVING FAMILY

ARLENE, STEPHEN, HEATHER, SOPHIA, LUNA, MAXWELL, ELIZABETH, PETER, ALEXANDER, CHARLOTTE, JULIETTE

You are an inspiration to us all.

A honor well deserved.

– CLAIRE LONEGAN AND TED WOJTECH

The Lymphoma Research Foundation’s mission is to eradicate lymphoma and serve those impacted by this blood cancer.